Fact Sheet
IQVIA Vigilance Detect for GLP-1 Therapies
Streamline pharmacovigilance with real-time detection of adverse events, off-label use, and product quality complaints using IQVIA Vigilance Detect.
Aug 07, 2025
Download
IQVIA Vigilance Detect is an AI-driven pharmacovigilance platform designed to monitor the expanding use of GLP-1 therapies. It identifies adverse events, product quality complaints, and off-label use across audio, email, chatbot logs, and scanned documents. With 99% transcription accuracy, the platform reduces manual workload and enhances regulatory compliance.

Related solutions

Contact Us